LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.14 | 771.67 | 12998 | 12592 | 1.0322 | 1.0158 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 87.14 | 771.67 | 13715 | 12592 | 1.0891 | 1.0428 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.49 | 771.67 | 879 | 867 | 1.0130 | 1.1581 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.49 | 771.67 | 1008 | 867 | 1.1616 | 3.8457 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.71 | 771.67 | 965 | 956 | 1.0090 | 1.0588 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.71 | 771.67 | 1137 | 956 | 1.1889 | 2.4971 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.94 | 771.67 | 1052 | 1045 | 1.0066 | 1.0302 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 6.94 | 771.67 | 1247 | 1045 | 1.1932 | 1.9943 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.16 | 771.67 | 1170 | 1138 | 1.0277 | 1.0997 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 9.16 | 771.67 | 1356 | 1138 | 1.1910 | 1.7312 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 11.56 | 771.67 | 1240 | 1280 | 0.9683 | 0.9137 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 11.56 | 771.67 | 1464 | 1280 | 1.1432 | 1.4019 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 13.78 | 771.67 | 1421 | 1459 | 0.9735 | 0.9423 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 13.78 | 771.67 | 1667 | 1459 | 1.1420 | 1.3106 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.00 | 771.67 | 1552 | 1585 | 0.9789 | 0.9593 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.00 | 771.67 | 1838 | 1585 | 1.1593 | 1.3057 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.22 | 771.67 | 1679 | 1741 | 0.9642 | 0.9388 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 18.22 | 771.67 | 2046 | 1741 | 1.1749 | 1.2943 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.44 | 771.67 | 1878 | 1910 | 0.9828 | 0.9736 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 20.44 | 771.67 | 2263 | 1910 | 1.1843 | 1.2760 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.66 | 771.67 | 2060 | 2141 | 0.9619 | 0.9480 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 22.66 | 771.67 | 2449 | 2141 | 1.1436 | 1.1908 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.89 | 771.67 | 2297 | 2397 | 0.9580 | 0.9482 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 24.89 | 771.67 | 2747 | 2397 | 1.1457 | 1.1734 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.11 | 771.67 | 2551 | 2675 | 0.9536 | 0.9477 | MN20160304_L01 | E09 |